Kragh-Hansen, et al., “Molecular Aspects of Ligand Binding to Serum Albumin”, Pharmacological Reviews, vol. 33, No. 1, pp. 17-53, 1981. |
Burke, et al., “Formulation, Stability, and Delivery of Live Attenuated Vaccines for Human Use”, Critical Reviews in Therapeutic Drug Carrier Systems, vol. 16, No. 1, pp. 1-83, 1999. |
Pickart, et al., “Alteration in Biological Properties of Human Albumin During Storage”, vol. 74, No. 3, pp. 961-968, 1977. |
Costantino, et al., “Heterogeneity of serum albumin samples with respect to solid-state aggreation via thiol-disulfide interchange—Implications for sustained release from polymers”, Journal of Controlled Release, vol. 44, pp. 255-261, 1997. |
Pikal, “Freeze-Drying of Proteins Part II: Formulation Selection”, BioPharm, Oct. 1990, pp. 26-30. |
MacKenzie, et al., “Collapse during freeze drying—qualitative and quantitative aspects”, In Freeze-Drying and Advance Food Technology, Academic Press (London), pp. 277-307, 1975. |
Tarelli, et al., “Recombinant Human Albumin as a Stabilizer for Biological Materials and for the Preparation of International Reference Reagents”, Biologicals, vol. 26, 1998, pp. 331-346. |
Kjeldsen, et al., “Secretory Expression of Human Albumin Domains in Saccharomyces cerevisiae and Their Binding of Myristic Acid and an Acylated Insulin Analogue”, Protein Expression and Purification, vol. 13, pp. 163-169, 1998. |
Harris, et al., “Observation of Albumin Resonances in Proton Nuclear Magnetic Resonance Spectra of Human Blood Plasma: N-Terminal Assignments Aided by Use of Modified Recombinant Albumin”, Analyst, Jul. 1996, vol. 121, pp. 913-922. |
Twine, et al., “Characterisation of domain fragments of recombinant human albumin”, Biochemical Society Transactions, vol. 26, 1988, p. S279. |
Ikegaya, et al., “Complete Determination of Disulfide Forms Purified Recombinant Human Serum Albumin, Secreted by the Yeast Pichia pastoris”. Anal. Chem., vol. 69, 1997, pp. 1986-1991. |
Ohtani, et al., “Analysis of Pichia pastoris Components in Recombinant Human Serum Albumin by Immunological Assays and by HPLC with Pulsed Amperometric Detection”, Anal. Chem., vol. 70, 1998, pp. 425-429. |
Ohtani, et al., “Physicochemical and Immunochemical Properties of Recombinant Human Serum Albumin from Pichia pastoris”, Analytical Biochemistry, vol. 256, 1998, pp. 56-62. |
Fitos, et al., “Binding Studies With Recombinant Human Serum Albumin Obtained By Expression Of A Synthetic Gene In Yeast”, Biochemical Pharmacology, vol. 46, No. 7, 1993, pp. 1159-1163. |
Quirk, et al., “Production of Recombinant Human Serum Albumin from Saccharomyces cerevisiae”, Biotechnology and Applied Biochemistry, vol. 11, 1989, pp. 273-287. |
Costantino, et al., “Aggregation of a Lyophilized Pharmaceutical Protein, Recombinant Human Albumin: Effect of Moisture and Stabilization by Excipients”, Biotechnology, vol. 13, May 1995, pp. 493-496. |
Brunell, et al., “Separation of Infectious Varicella-Zoster Virus from Human Embryonic Lung Fibroblasts”, Virology, vol. 31, 1967, 732-734. |
Rapp, “Inhibition by Metabolic Analogues of Plaque Formation by Herpes Zoster and Herpes Simplex Viruses”, J. Immunol., vol. 93, 1964, pp. 643-648. |
Plotkin, et al., “Chapter 23—Rabies Vaccine”, Vaccines—Second Edition, 1994, pp. 649-670. |
“Use of Recombinant Human Albumin in the Formulation of Proteins,” Research Disclosure, published by Kenneth Mason Publications, Ltd. Aug. 1995, No. 376, p. 516, disclosed anonymously. |
Asano, et al., “Studies on Neutralization of Varicella-Zoster Virus and Serological Follow-up of Cases of Varicella and Zoster”, Biken Journal, vol. 21, pp. 15-23, 1978. |
Takahashi, et al., “Development of a Live Attenuated Varicella Vaccine”, Biken Journal, vol. 18, pp. 25-33, 1975. |
Krah, et al., “Enhancement of varicella-zoster virus plaquing efficiency with an agarose overlay medium”, J. of Virol., Methods, vol. 27, pp. 319-326, 1990. |
Costantino, et al., “Aggregation of a Lyophilized Pharmaceutical Protein, Recombinant Human Albumin . . . ”, Biotechnology, vol. 13, pp. 493-496, May 1995. |
Day, et al., “Nonenzymatically Glucosylated Albumin”, The Journal of Biological Chemistry, vol. 254, No. 3, pp. 595-597, Feb. 10, 1979. |
Dodsworth, et al., “Comparative studies of recombinant human albumin and human serum albumin . . . ”, Biotechnol. Appl. Biochem., vol. 24, pp. 171-176, 1996. |
Bennett, et al., “The Effects of Freeze-Drying on the Potency and Stability of Live Varicella Virus Vaccine”, International Symposium on Biol. Product Freeze-Drying and Formulation, Bethesda, USA, Develop. Biol. Standard, vol. 74, pp. 215-221, 1991. |
Howell, et al., “Effect of Sucrose Phosphate and Sorbitol on Infectivity of Enveloped Viruses During Storage”, J. of Clin. Microb., pp. 658-662, Sep. 1983. |
Bovarnick, et al., “The Influence of Certain Salts, Amino Acids, Sugars, and Proteins on the Stability of Rickettsiae”, J. Bact., vol. 59, pp. 509-522, 1950. |
1997 Edition of the Physician's Desk Reference, pp. 1807-1910, 1997. |
1997 Edition of the Physician's Desk Reference, pp. 1730-1732, 1997. |